Diabetes Care
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Diabetes Care Publish Ahead of Print published online ahead of print March 23, 2007
DOI: 10.2337/dc06-1357

This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
dc06-1357v1
30/6/1364    most recent
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yki-Järvinen, H.
Right arrow Articles by Vähätalo, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yki-Järvinen, H.
Right arrow Articles by Vähätalo, M.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Original Research

INITIATE (INITiate Insulin by Aggressive Titration and Education). A randomized study to compare initiation of insulin combination therapy in type 2 diabetic patients individually and in groups

Hannele Yki-Järvinen, M.D., F.R.C.P.1, Leena Juurinen, M.D.1,2, Michael Alvarsson, M.D.3, Tord Bystedt, M.D.3, Ian Caldwell, M.D.4, Melanie Davies, M.D.5, Sanni Lahdenperä, M.D.6, Gil Nijpels, M.D.7 and Markku Vähätalo, M.D.8

1University of Helsinki, Helsinki, Finland
2Minerva Institute for Medical Research, Helsinki, Finland
3Endocrinology, Metabolism and Diabetes, Karolinska University Hospital, Stockholm, Sweden
4Swan Lane Medical Centre, Bolton, UK
5Leicester Royal Infirmary, Leicester, UK
6sanofi-aventis, Helsinki, Finland
7VU University Medical Center, Amsterdam, Netherlands
8Turku Health Center, Turku, Finland

ykijarvi{at}cc.helsinki.fi

ABSTRACT

Background.: Insulin is often postponed for years because initiation is time-consuming.

Objectives.: To compare initiation of insulin individually (IND) and in groups (GROUP) with respect to change in HbA1c and several other parameters in type 2 diabetic patients.

Design:: A randomized (1:1), multi-center two-arm parallel design study with a recruiting period of up to 14 weeks and a 24-week treatment period. 121 insulin-naïve type 2 diabetic patients with an HbA1c of 7.0-12.0 % were randomized to initiate bedtime insulin glargine either in groups of 4-8 or individually using the same personnel and education program. The patients visited the treatment center before, at the time of insulin initiation and at 6, 12 and 24 weeks. Patients self-adjusted the insulin dose to achieve a fasting plasma glucose of 4.0-5.5 mmol/l.

Results.: At 24 weeks, HbA1c had decreased from 8.7±0.2 to 6.9±0.1% in IND and from 8.8±0.2 to 6.8±0.1% in GROUP (NS).Insulin doses averaged 62±5 IU and 56±5 IU at 24 weeks (NS), respectively. The frequency of hypoglycemia was similar. The total time (visits and phone calls) spent in initiating insulin in GROUP (2.2±0.1 hrs) was 48% less than in IND (4.2±0.2 hrs). Diabetes treatment satisfaction improved significantly in both groups.

Conclusions.: Similar glycemic control and treatment satisfaction can be achieved by initiating insulin in groups and individually. Starting insulin in groups takes half as much time as individual initiation.


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Clin. DiabetesHome page
A. M. Davis, D. R. Sawyer, and L. M. Vinci
The Potential of Group Visits in Diabetes Care
Clin. Diabetes, April 1, 2008; 26(2): 58 - 62.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
M. C. Riddle
Starting and Advancing Insulin for Type 2 Diabetes: Algorithms and Individualized Methods Are Both Necessary
J. Clin. Endocrinol. Metab., February 1, 2008; 93(2): 372 - 374.
[Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
L. Juurinen, A. Kotronen, M. Graner, and H. Yki-Jarvinen
Rosiglitazone Reduces Liver Fat and Insulin Requirements and Improves Hepatic Insulin Sensitivity and Glycemic Control in Patients with Type 2 Diabetes Requiring High Insulin Doses
J. Clin. Endocrinol. Metab., January 1, 2008; 93(1): 118 - 124.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
R. R. Holman, K. I. Thorne, A. J. Farmer, M. J. Davies, J. F. Keenan, S. Paul, J. C. Levy, and the 4-T Study Group
Addition of Biphasic, Prandial, or Basal Insulin to Oral Therapy in Type 2 Diabetes
N. Engl. J. Med., October 25, 2007; 357(17): 1716 - 1730.
[Abstract] [Full Text] [PDF]


Home page
JWatch GeneralHome page
Initiating Insulin Therapy in Group Sessions
Journal Watch (General), July 10, 2007; 2007(710): 4 - 4.
[Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2007 by the American Diabetes Association.